The KeyIdea - Company finances
|
EUR
|
2024
From: 2024-03-26
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 11,990 | 89,854 |
| Profit before tax | 211 | 1,467 |
| Net profit | 211 | 1,379 |
| Equity | 212 | 1,592 |
| Liabilities | 0 | 386 |
| Non-current assets | 0 | 1,053 |
| Current assets | 212 | 925 |
| Total assets | 212 | 1,978 |
|
Taxes paid
|
||
| STI taxes | - | 9,318 |
|
Financial indicators
|
||
| Revenue change y/y | - | +649.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 99.5% | 69.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 99.5% | 86.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.8% | 1.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.8% | 1.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
The KeyIdea - Social security debts
The company had no debts to Sodra
The KeyIdea - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-10-30 | 2025-11-22 | 4.5 |
| 2025-10-02 | 2025-10-24 | 4.5 |
| 2025-09-30 | 2025-10-01 | 4.32 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
The KeyIdea, MB (code 306712331) is a Small partnership engaged in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €89.9K, up 649.4% from €12.0K in 2024. Net profit reached €1.4K in 2025, compared with €211 a year earlier, while the profit margin remained modest at 1.5%, indicating that profitability improved in absolute terms but stayed narrow relative to sales. The 2025 balance sheet shows total assets of €2.0K, equity of €1.6K and liabilities of €386, with long-term assets of €1.1K and short-term assets of €925. The equity ratio stood at 80.5% and the debt-to-equity ratio at 0.24, suggesting limited leverage. Asset turnover was very high at 45.43x, reflecting the small asset base relative to turnover. Returns on equity and assets were strong in 2025, but these figures should be viewed in the context of the company’s very small equity and asset base.